IART - INTEGRA LIFESCIENCES HOLDINGS CORP
IEX Last Trade
22.335
-0.035 -0.157%
Share volume: 12,380
Last Updated: Fri 27 Dec 2024 08:30:11 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$22.37
-0.04
-0.16%
Fundamental analysis
13%
Profitability
17%
Dept financing
25%
Liquidity
39%
Performance
0%
Performance
5 Days
3.13%
1 Month
-7.50%
3 Months
27.03%
6 Months
-21.04%
1 Year
-48.27%
2 Year
-59.57%
Key data
Stock price
$22.34
DAY RANGE
$22.10 - $22.65
52 WEEK RANGE
$17.22 - $45.42
52 WEEK CHANGE
-$47.88
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: Jan D. de Witte
Region: US
Website: integralife.com
Employees: 3,720
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: integralife.com
Employees: 3,720
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, surgical headlamps and instrumentation.
Recent news